Literature DB >> 12364591

Reversible inhibition of the second step of splicing suggests a possible role of zinc in the second step of splicing.

Noam Shomron1, Hadar Malca, Ida Vig, Gil Ast.   

Abstract

A multicomponent complex of proteins and RNA is assembled on the newly synthesized pre-mRNA to form the spliceosome. This complex catalyzes a two-step transesterification reaction required to remove the introns and ligate the exons. To date, only six proteins have been found necessary for the second step of splicing in yeast, and their human homologs have been identified. We demonstrate that the addition of the selective chelator of zinc, 1,10-phenanthroline, to an in vitro mRNA splicing reaction causes a dose-dependent inhibition of the second step of splicing. This inhibition is accompanied by the accumulation of spliceosomes paused before completion of step two of the splicing reaction. The inhibition effect on the second step is due neither to snRNA degradation nor to direct binding to the mRNA, and is reversible by dialysis or add-back of zinc, but not of other divalent metals, at the beginning of the reaction. These findings suggest that the activity of a putative zinc-dependent metalloprotein(s) involved in the second step of splicing is affected. This study outlines a new method for specific reversible inhibition of the second step of splicing using external reagents, and suggests a possible role of divalent cations in the second step of mRNA splicing, most likely zinc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12364591      PMCID: PMC140552          DOI: 10.1093/nar/gkf553

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  63 in total

Review 1.  Zinc finger peptides for the regulation of gene expression.

Authors:  A Klug
Journal:  J Mol Biol       Date:  1999-10-22       Impact factor: 5.469

Review 2.  Exonic splicing enhancers: mechanism of action, diversity and role in human genetic diseases.

Authors:  B J Blencowe
Journal:  Trends Biochem Sci       Date:  2000-03       Impact factor: 13.807

3.  Functional association of U2 snRNP with the ATP-independent spliceosomal complex E.

Authors:  R Das; Z Zhou; R Reed
Journal:  Mol Cell       Date:  2000-05       Impact factor: 17.970

4.  Composition and functional characterization of the yeast spliceosomal penta-snRNP.

Authors:  Scott W Stevens; Daniel E Ryan; Helen Y Ge; Roger E Moore; Mary K Young; Terry D Lee; John Abelson
Journal:  Mol Cell       Date:  2002-01       Impact factor: 17.970

5.  A role for a TIMP-3-sensitive, Zn(2+)-dependent metalloprotease in mammalian gamete membrane fusion.

Authors:  L M Correa; C Cho; D G Myles; P Primakoff
Journal:  Dev Biol       Date:  2000-09-01       Impact factor: 3.582

Review 6.  The question remains: is the spliceosome a ribozyme?

Authors:  C A Collins; C Guthrie
Journal:  Nat Struct Biol       Date:  2000-10

7.  Copper-mediated toxicity of 2,4,5-trichlorophenol: biphasic effect of the copper(I)-specific chelator neocuproine.

Authors:  B Z Zhu; M Chevion
Journal:  Arch Biochem Biophys       Date:  2000-08-15       Impact factor: 4.013

8.  PRP16 is an RNA-dependent ATPase that interacts transiently with the spliceosome.

Authors:  B Schwer; C Guthrie
Journal:  Nature       Date:  1991-02-07       Impact factor: 49.962

9.  Two domains of yeast U6 small nuclear RNA required for both steps of nuclear precursor messenger RNA splicing.

Authors:  P Fabrizio; J Abelson
Journal:  Science       Date:  1990-10-19       Impact factor: 47.728

10.  PRP18, a protein required for the second reaction in pre-mRNA splicing.

Authors:  U Vijayraghavan; J Abelson
Journal:  Mol Cell Biol       Date:  1990-01       Impact factor: 4.272

View more
  8 in total

1.  The U1 snRNP base pairs with the 5' splice site within a penta-snRNP complex.

Authors:  Hadar Malca; Noam Shomron; Gil Ast
Journal:  Mol Cell Biol       Date:  2003-05       Impact factor: 4.272

2.  Splicing factor hSlu7 contains a unique functional domain required to retain the protein within the nucleus.

Authors:  Noam Shomron; Mika Reznik; Gil Ast
Journal:  Mol Biol Cell       Date:  2004-06-04       Impact factor: 4.138

3.  An artificial riboswitch for controlling pre-mRNA splicing.

Authors:  Dong-Suk Kim; Veronica Gusti; Sailesh G Pillai; Rajesh K Gaur
Journal:  RNA       Date:  2005-11       Impact factor: 4.942

4.  Molecular architecture of zinc chelating small molecules that inhibit spliceosome assembly at an early stage.

Authors:  Vishal Patil; Josh C Canzoneri; Timur R Samatov; Reinhard Lührmann; Adegboyega K Oyelere
Journal:  RNA       Date:  2012-07-25       Impact factor: 4.942

5.  Ribonucleotide reductase as one important target of [Tris(1,10-phenanthroline)lanthanum(III)] trithiocyanate (KP772).

Authors:  P Heffeter; A Popovic-Bijelic; P Saiko; R Dornetshuber; U Jungwirth; N Voevodskaya; D Biglino; M A Jakupec; L Elbling; M Micksche; T Szekeres; B K Keppler; A Gräslund; W Berger
Journal:  Curr Cancer Drug Targets       Date:  2009-08-01       Impact factor: 3.428

6.  Environmental stresses inhibit splicing in the aquatic fungus Blastocladiella emersonii.

Authors:  Raphaela Castro Georg; Rosane M P Stefani; Suely Lopes Gomes
Journal:  BMC Microbiol       Date:  2009-10-29       Impact factor: 3.605

7.  Physiological state co-regulates thousands of mammalian mRNA splicing events at tandem splice sites and alternative exons.

Authors:  Karol Szafranski; Claudia Fritsch; Frank Schumann; Lisa Siebel; Rileen Sinha; Jochen Hampe; Michael Hiller; Christoph Englert; Klaus Huse; Matthias Platzer
Journal:  Nucleic Acids Res       Date:  2014-07-16       Impact factor: 16.971

8.  Presynaptic dysfunction in CASK-related neurodevelopmental disorders.

Authors:  Martin Becker; Francesca Mastropasqua; Jan Philipp Reising; Simon Maier; Mai-Lan Ho; Ielyzaveta Rabkina; Danyang Li; Janina Neufeld; Lea Ballenberger; Lynnea Myers; Viveka Moritz; Malin Kele; Josephine Wincent; Charlotte Willfors; Rouslan Sitnikov; Eric Herlenius; Britt-Marie Anderlid; Anna Falk; Sven Bölte; Kristiina Tammimies
Journal:  Transl Psychiatry       Date:  2020-09-14       Impact factor: 6.222

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.